Introduction: Limitations of biomarkers and imaging are a concern in the identification of NET status and therapy response.
Aim(s): To identify if circulating molecular markers and imaging provided added value, we assessed the utility of 68Ga-SSA-PET, Ki-67, CgA, and circulating NET transcripts (NETest).
Materials and methods: In two independent datasets (1, pre-PRRT, n=27; 2, follow up, n=22) we evaluated SUVmax, Ki-67, CgA and NETest (regression analyses, generalized linear modeling, ROC analyses).
Conference: 12th Annual ENETS Conference 2015 (2015)
Presenting Author: MD, PhD Lisa Bodei
, Kidd M
, Modlin I
, Drozdov I
, Prasad V
, Severi S
, Ambrosini V
, Kwekkeboom D
, Krenning E
, Baum R
, Paganelli G
To read results and conclusion, please login ...
Further abstracts you may be interested in